• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Amicus Therapeutics Inc

+ Add to Watchlist

FOLD:US

3.8600 USD 0.0700 1.85%

As of 20:10:00 ET on 07/10/2014.

Snapshot for Amicus Therapeutics Inc (FOLD)

Open: 3.7100 Day's Range: 3.6500 - 3.9800 Volume: 773,788
Previous Close: 3.7900 52wk Range: 1.7650 - 4.3100 1-Yr Rtn: +67.83%

Stock Chart for FOLD

No chart data available.
  • FOLD:US 3.8600
  • 1D
  • 1M
  • 1Y
3.7900
Interactive FOLD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for FOLD

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.0373
Est. EPS (USD) (12/2014) -0.9300
Est. PEG Ratio -
Market Cap (M USD) 248.35
Shares Outstanding (M) 64.34
30 Day Average Volume 2,308,957
Price/Book (mrq) 7.9898
Price/Sale (ttm) 282.9988
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for FOLD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for FOLD

Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease.

John F CrowleyChairman/CEOWilliam D Baird III "Chip"Chief Financial Officer
Bradley L CampbellChief Operating OfficerJay BarthChief Medical Ofcr
More Company Profile & Key Executives for FOLD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil